1. Home
  2. COHU vs IOVA Comparison

COHU vs IOVA Comparison

Compare COHU & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohu Inc.

COHU

Cohu Inc.

HOLD

Current Price

$29.99

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.51

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHU
IOVA
Founded
1947
2007
Country
United States
United States
Employees
N/A
975
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
COHU
IOVA
Price
$29.99
$3.51
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$34.00
$9.11
AVG Volume (30 Days)
503.3K
15.9M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
$452,956,000.00
N/A
Revenue This Year
$14.38
$51.55
Revenue Next Year
$19.12
$37.55
P/E Ratio
N/A
N/A
Revenue Growth
12.74
N/A
52 Week Low
$12.59
$1.64
52 Week High
$34.96
$5.63

Technical Indicators

Market Signals
Indicator
COHU
IOVA
Relative Strength Index (RSI) 50.47 45.36
Support Level $27.53 $2.02
Resistance Level $31.18 $4.34
Average True Range (ATR) 1.41 0.33
MACD 0.16 -0.13
Stochastic Oscillator 51.39 5.87

Price Performance

Historical Comparison
COHU
IOVA

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: